New
Treatment Option for Severe Depression US FDA Approves the Vagus Nerve Stimulator |
August 15, 2005 On July 15, 2005, the US Food and Drug Administration (FDA) approved a new treatment for people affected by severe depression: an implanted device that sends electrical shocks to the vagus nerve. The "Vagus Nerve Stimulation Therapy System (VNS) is manufactured by Cyberonics, Inc., and was approved in 1997 to treat epilepsy. The VNS must be surgically implanted in the chest with wires connecting a pulse generator to the vagus nerve in the patient's neck. Electrical stimulation of the vagus nerve is thought to relieve depression by sending signals to brain areas important for mood. These signals may affect neurotransmitter activity in the brain. |
Did you know? |
|
References and
more
information about VNS Therapy:
|
BACK TO: | Neuroscience in the News | Table of Contents |
Send E-mail |
Fill out survey |
Get Newsletter |
Search Pages |